Rashesh Shah, MD
Interventional Cardiology · Somerset, NJNPI 1376999367
Payments from drug & device makers
Across 174 payments — averaging $76.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$3K
- Medtronic$2K
- Atricure, Inc.$2K
- Edwards Lifesciences$1K
- Boston Scientific$797
- Abiomed$750
- plus $3K from 19 others
What the payments were for
- Travel & lodging$3,38725%
- Food & beverage$9,12268%
- Education$8116%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 26 | $2,774 |
| Medtronic | 25 | $2,346 |
| Atricure, Inc. | 23 | $2,180 |
| Edwards Lifesciences | 12 | $1,011 |
| Boston Scientific | 11 | $797 |
| Abiomed | 13 | $750 |
| Shockwave Medical, Inc | 6 | $587 |
| Philips North America LLC | 3 | $414 |
| AstraZeneca | 7 | $378 |
| Cardiovascular Systems Inc. | 4 | $369 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 8 | $339 |
| Kestra Medical Technology Services, Inc. | 5 | $325 |
| Pfizer | 10 | $230 |
| Astellas Pharma US Inc | 2 | $179 |
| E.r. Squibb & Sons, L.L.C. | 6 | $163 |
| GE HealthCare | 1 | $100 |
| Teleflex LLC | 1 | $98 |
| Chiesi USA, Inc. | 1 | $79 |
| Johnson & Johnson | 2 | $52 |
| W. L. Gore & Associates, Inc. | 3 | $50 |
| Stryker | 1 | $38 |
| Terumo Medical Corporation | 1 | $19 |
| Actelion Pharmaceuticals US, Inc. | 1 | $15 |
| Amgen | 1 | $15 |
| GSK | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NAVITOR$1,664
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$1,540
- COREVALVE EVOLUT R$1,110
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$516
- Edwards SAPIEN 3 Transcatheter Heart Valve$426
- RESOLUTE ONYX$342
- Diamondback Coronary$311
- SYNERGY ABLATION SYSTEM$306
- (9520) IGT Devices Undivided$298
- ENSITE$209
- Diamondback Peripheral$163
- Ensite Cardiac Mapping System$152
- SAPIEN 3 Ultra RESILIA$148
- MAMBA$147
- SYNERGY$142
- Assure WCD$141
- MitraClip$135
- Watchman$119
- WAINUA$114
- HeartMate 3 Left Ventricular Dev$109
How this compares
$13,320 in reported general payments places this provider in the 60th percentile of 166 interventional cardiology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 18 | $277 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Somerset
- Dinesh SingalSomerset$1.4M
- Jack StrohSomerset$62K
- Ankitkumar PatelGlen Ridge$717K
- Matthew SayboltEatontown$671K
- Jaffar RazaSecaucus$537K
- Kintur SanghviBordentown$467K
- Ziad AbbudOcean$361K
- Ramin HastingsHasbrouck Heights$355K
- Ryan KapleHackensack$280K
- Haroon FarazTeaneck$269K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.